AMPLY Discovery, established in 2021, is a spin-out from Queen's University Belfast, located in Belfast, Northern Ireland. The company stands at the forefront of innovation with its slogan, "Novel Biologics. Designed by Evolution. Discovered by AI."
Specializing in a unique blend of AI, Biotechnology, Health Care, and Pharmaceutical industries, AMPLY Discovery utilizes cutting-edge machine learning and synthetic biology to excavate extensive biological data. Their proprietary in silico and in vitro hybrid platform aims to identify best-in-class molecules, striving to combat critical challenges like cancer, MDR infections, and metabolic diseases.
Recently, AMPLY Discovery secured an Early VC investment on 01 January 2026 from KPS Inc.. This funding round positions the company well for advancing its ambitious projects, promising potential breakthroughs in biologic drug discovery and nutraceuticals.